BIAF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioAffinity Technologies Inc (BIAF) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock shows bearish technical indicators, weak financial performance, and lacks positive catalysts or trading signals. Given the user's preference for long-term investments, it is better to wait for stronger signs of growth and stability before considering this asset.
The technical indicators suggest a bearish trend. The MACD is negatively expanding below zero (-0.211), RSI is at 20.655 (neutral zone), and moving averages indicate a bearish pattern (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the next support at 2.035.
NULL identified. No recent news or significant trading activity from hedge funds, insiders, or Congress.
The stock has experienced a -8.37% regular market decline, with further post-market losses of -1.45%. Financial performance shows declining revenue (-27.85% YoY) and EPS (-88.37% YoY). Technical indicators and trading trends are bearish.
In Q4 2025, revenue dropped by -27.85% YoY to $1,592,813. Net income improved slightly but remains negative at -$3,137,466 (+5.75% YoY). EPS fell significantly to -0.7 (-88.37% YoY). Gross margin increased to 35.72% (+60.32% YoY), but this improvement is overshadowed by declining revenue and EPS.
No analyst ratings or price target changes available.
